The study hypothesis is that the Xal-Ease with increase patient compliance with XALATAN
- 40 to 80 years old
- Diagnosis warranting treatment with Xalatan eye drops.
- ambulatory and well functioning
- less than 40 or greater than 80 years old
- Not using Xalatan eye drops